This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.
Nature reviews. Endocrinology · 2025
Research ethics and stem cells: Is it time to re-think current approaches to oversight?
EMBO reports · 2015
Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
Diabetes · 2013
Latest funding
- $1,082,476
Graft localized drug delivery to augment beta cell replacement therapies for diabetes
CIHR · 2023 · Co-investigator
- $135,000
Graft localized therapeutic delivery systems to enhance beta cell engraftment
CIHR · 2023 · Supervisor
- $1,000,000
A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
CIHR · 2021 · Principal investigator
14 publications.
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.
Grattoni A, Korbutt G, Tomei AA, García AJ, Pepper AR, Stabler C, Brehm M, Papas K, Citro A, Shirwan H, Millman JR, Melero-Martin J, Graham M, Sefton M, Ma M, Kenyon N, Veiseh O, Desai TA, Nostro MC, Marinac M, Sykes M, Russ HA, Odorico J, Tang Q, Ricordi C, Latres E, Mamrak NE, Giraldo J, Poznansky MC, de Vos P
Research ethics and stem cells: Is it time to re-think current approaches to oversight?
Caulfield T, Kamenova K, Ogbogu U, Zarzeczny A, Baltz J, Benjaminy S, Cassar PA, Clark M, Isasi R, Knoppers B, Knowles L, Korbutt G, Lavery JV, Lomax GP, Master Z, McDonald M, Preto N, Toews M
Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
Pulinilkunnil T, Kienesberger PC, Nagendran J, Waller TJ, Young ME, Kershaw EE, Korbutt G, Haemmerle G, Zechner R, Dyck JR
Functional plasticity of the human infant β-cell exocytotic phenotype.
Fox JE, Seeberger K, Dai XQ, Lyon J, Spigelman AF, Kolic J, Hajmrle C, Joseph JW, Kin T, Shapiro AM, Korbutt G, MacDonald PE
Milrinone, dobutamine or epinephrine use in asphyxiated newborn pigs resuscitated with 100% oxygen.
Joynt C, Bigam DL, Charrois G, Jewell LD, Korbutt G, Cheung PY
Intestinal hemodynamic effects of milrinone in asphyxiated newborn pigs after reoxygenation with 100% oxygen: a dose-response study.
Joynt C, Bigam DL, Charrois G, Jewell LD, Korbutt G, Cheung PY
Effects of N-acetylcysteine on intestinal reoxygenation injury in hypoxic newborn piglets resuscitated with 100% oxygen.
Johnson ST, Bigam DL, Emara M, Slack G, Jewell LD, Obaid L, Korbutt G, Van Aerde J, Cheung PY
Dose-response effects of milrinone on hemodynamics of newborn pigs with hypoxia-reoxygenation.
Joynt C, Bigam DL, Charrois G, Jewell LD, Korbutt G, Cheung PY
Cardio-renal recovery of hypoxic newborn pigs after 18%, 21% and 100% reoxygenation.
Cheung PY, Obaid L, Emara M, Brierley Y, Johnson ST, Chan GS, Jewell L, Korbutt G, Bigam DL
Oxidative stress and matrix metalloproteinase-9 activity in the liver after hypoxia and reoxygenation with 21% or 100% oxygen in newborn piglets.
Stevens JP, Churchill T, Fokkelman K, Haase E, Idikio H, Korbutt G, Bigam DL, Cheung PY
Graft localized drug delivery to augment beta cell replacement therapies for diabetes
Principal investigators: Pepper, Andrew R
Keywords: Beta Cells; Biomaterials; Cell Thearpies; Diabetes; Immunosuppression; Insulin; Islets; Transplantation
Graft localized therapeutic delivery systems to enhance beta cell engraftment
Principal investigators: Cuesta Gomez, Nerea
Keywords: Diabetes; Gmp Cell Manufacturing; Islet Transplantation; Scaffolds
A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
Principal investigators: Shapiro, James; Kieffer, Timothy J; Korbutt, Gregory S; MacDonald, Patrick E; Pepper, Andrew R
Keywords: Autoimmunity; Autologous Human Ipscs; Beta Cell Replacement Therapy; Cell Replacement Therapy; Clinical Trial; Diabetes Treatment; Induced Pluripotent Stem Cells; Islet Transplantation; Personalized Cell Therapy; Stem Cell Biology
A First-in-human Trial of Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
Principal investigators: Shapiro, James; Kieffer, Timothy J; Korbutt, Gregory S; MacDonald, Patrick E; Pepper, Andrew R
Keywords: Beta Cell Replacement Therapy; Induced Pluripotent Stem Cells; Treatment For Diabetes
Translational strategies for the clinical transplantation of human islets and mesenchymal stem cells.
Principal investigators: Korbutt, Gregory S; Shapiro, James
Keywords: Diabetes; Islet Transplantation
Stem Cell Network/Réseau de cellules souches
Principal investigators: Rudnicki, Michael
Translational strategies for the clinical transplantation of neonatal porcine islets.
Principal investigators: Korbutt, Gregory S
Keywords: Diabetes; Islet Transplantation
Stem Cell Network/Réseau de cellules souches
Principal investigators: Rudnicki, Michael
The Canadian Regenerative Medicine Network (CRM-Net) / Le Réseau Canadien de Médecine Régénérative
Principal investigators: Sefton, Michael
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pediatrics
- Surgery
- Human Genetics
- Obstetrics and Gynecology
- Institute of Biomaterials and Biomedical Engineering
- Other
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Po-Yin Cheung
Pediatrics
9 shared papers, latest 2010
Timothy Caulfield
Pediatrics
1 shared papers, latest 2015
Ubaka Ogbogu
Faculty
1 shared papers, latest 2015
Bartha Knoppers
Human Genetics
1 shared papers, latest 2015
Jay Baltz
Obstetrics and Gynecology
1 shared papers, latest 2015
Michael Sefton
Institute of Biomaterials and Biomedical Engineering
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.